Small-cell carcinoma of the uterus and the vagina: experience with ten patients
- 127 Downloads
Small cell carcinomas (small-CCs) of the uterine cervix are rare and highly malignant neoplasms. Patients tend to develop distant metastasis early and thus are potential candidates for systemic therapy. We reviewed the experience with small-CCs of the uterus and vagina at two Austrian University hospitals.
Material and methods
Ten patients (median age, 50 years; range, 18–92) with small-CC of the cervix (n=7), uterine corpus (n=2), and the vagina (n=1) were treated at the two centers between 1988 and 1998. Eight patients underwent radical surgery, 7 of whom also received chemotherapy. Two additional patients underwent primary radiotherapy.
All Pap smears were suspicious for cervical malignancy. The median survival was 12 months (range, 6–86) and overall 5-year survival was 10%. Five of 8 surgically treated patients had lymph node involvement (62%). Of the 7 patients with small-CC of the cervix only one, who had FIGO stage IIB disease and positive pelvic nodes, survived long-term (86 months) with no evidence of disease. She had received six courses of dose-intensive platinum chemotherapy after radical surgery. All three patients with small-CC of the uterine corpus or vagina developed recurrence within the first year after diagnosis. Of the 7 patients who received chemotherapy, 5 developed progressive or recurrent disease in the paraaortic region (n=2), peritoneum (n=1), liver (n=1), or pelvis (n=1).
These results confirm the particularly unfavorable prognosis of patients with small-CC of the genital tract. The optimal treatment for these patients most probably including concurrent chemo-radiotherapy remains to be defined.
KeywordsSmall cell carcinoma Uterine cervix Adjuvant chemotherapy Neuroendocrine carcinoma
- 2.Lewandowski G, Copeland L (1993) A potential role for intensive chemotherapy in the treatment of small cell neuroendocrine tumors of the cervix. Gynecol Oncol 48:127–131Google Scholar
- 3.O’Hanlan K, Goldberg G, Jones J, Runowicz C, Ehrlich L, Rodriguez L (1991) Adjuvant therapy for neuroendocrine small cell carcinoma of the cervix. Gynecol Oncol 43:167–172Google Scholar
- 4.Delagoge S, Pautier P, Kerbrat P, Castaigne D, Haie-Meder C, Duvilla P, Guivarch C, Goupil A, Borel C, Lhomme C (2000) Neuroendocrine small cell carcinoma of the uterine cervix: what disease? what treatment? Report of ten cases and review of the literature. Clin Oncol 12:357–362CrossRefGoogle Scholar
- 11.Sheets E, Berman M, Hrountas C, Liao S, DiSaia P (1988) Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 71:10–14Google Scholar
- 21.Kim Y, Barbuto D, Lagasse L, Karlan B (1996) Successful treatment of neuroendocrine small cell carcinoma of the cervix metastatic to the regional lymph nodes. Gynecol Oncol 62:411–414Google Scholar
- 22.Abulafia O, Sherer D (1995) Adjuvant chemotherapy in stage Ib neuroendocrine small cell carcinoma of the cervix. Acta Obstet Scand 74:740–744Google Scholar
- 26.Hoskins P, Swenerton K, Pike J, Lim P, Aquino-Parsons C, Wong F, Lee N (2003) Small cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 21:3495–3501CrossRefPubMedGoogle Scholar